GENE ONLINE|News &
Opinion
Blog

2020-06-10| PartnerAsia-Pacific

Nobel Laureate Dr. Honjo to Speak at BIO Asia–Taiwan 2020

by GeneOnline
Share To
 
 

Dr. Tasuku Honjo (本庶 佑), Distinguished Professor of Kyoto University, Japan, shared the 2018 Nobel Prize in Medicine or Physiology for his contributions to the immune checkpoint blockade approach in cancer immunotherapy. His discoveries have been responsible in saving thousands of lives.

We are honored to announce that Dr. Tasuku Honjo will join us at BIO Asia–Taiwan 2020 as a Plenary Speaker, with his presentation titled “Future of
Cancer Immunotherapy“.
 
The Early Bird special ends this week! Don’t miss your chance to join thousands of bioindustry professionals from Asia and around the world at BIO Asia–Taiwan 2020 Online + Live!
BIO Asia-Taiwan 2020 Secretariat

register@taiwanbio.org.tw | www.bioasiataiwan.com | +886-2-7700-3883

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Author
GeneOnline
Related Post
Special
BIO Asia-Taiwan 2022: Looking for the Exit; Startup Considerations and Strategies
2022-07-28
Special
BIO Asia-Taiwan 2022: Top iPS Cell Technologies at Affordable Prices – Keynote by Nobel Laureate Shinya Yamanaka
2022-07-28
Special
Reinvigorating the Asian Biomedical Ecosystem With BIO Asia-Taiwan 2022
2022-07-26
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
READ MORE
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top